Related Experiment Videos
Hepatitis E
1Hepatitis Branch, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia.
Gastroenterology Clinics of North America
|September 1, 1994
Summary
New diagnostic tests enhance understanding of Hepatitis E virus (HEV) infection, revealing long-lasting immunity and potential for vaccines. HEV is a common cause of acute hepatitis in children in endemic areas.
Area of Science:
- Virology
- Hepatology
- Immunology
Background:
- Hepatitis E virus (HEV) is a significant cause of acute hepatitis globally.
- Understanding HEV pathogenesis and long-term immunity has been limited.
- Diagnostic challenges have historically complicated HEV diagnosis.
Purpose of the Study:
- To enhance the understanding of Hepatitis E virus (HEV) pathogenesis and immune responses.
- To investigate the prevalence of HEV in pediatric populations.
- To explore the potential for developing a recombinant vaccine against HEV.
Main Methods:
- Utilized new, noncommercial diagnostic tests for HEV detection.
- Delineated the process of pathogenesis in infected humans.
- Analyzed IgG response to HEV for long-lasting immunity.
Main Results:
- New diagnostic tests have greatly enhanced the understanding of HEV.
- HEV is the most common cause of acute sporadic hepatitis in pediatric populations in endemic regions.
- An IgG response to HEV is long-lasting and may confer immunity.
Conclusions:
- Advances in diagnostics are improving HEV understanding and management.
- HEV poses a significant public health challenge, particularly in pediatric populations.
- The potential for a recombinant HEV vaccine is promising, pending further development and commercial availability.